Paul Termini
Psychiatry · Moosic, PANPI 1427125764
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 800 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 9.8% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 800 payments — averaging $14.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$954
- Neurocrine Biosciences, Inc.$860
- AbbVie$742
- plus $6K from 23 others
What the payments were for
- Food & beverage$11,66499%
- Education$861%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 58 | $1,146 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 67 | $1,106 |
| Otsuka America Pharmaceutical, Inc. | 68 | $1,072 |
| Teva Pharmaceuticals USA, Inc. | 74 | $954 |
| Neurocrine Biosciences, Inc. | 67 | $860 |
| AbbVie | 67 | $742 |
| Takeda Pharmaceuticals U.S.A., Inc. | 54 | $656 |
| Johnson & Johnson | 43 | $624 |
| Bausch Health US, LLC | 33 | $623 |
| Ironshore Pharmaceuticals Inc. | 55 | $505 |
| Axsome Therapeutics, Inc. | 21 | $353 |
| Vanda Pharmaceuticals Inc. | 25 | $352 |
| Eisai Inc. | 15 | $329 |
| Corium, LLC | 25 | $323 |
| Jazz Pharmaceuticals Inc. | 19 | $308 |
| Lundbeck LLC | 21 | $264 |
| Supernus Pharmaceuticals, Inc. | 13 | $259 |
| Alfasigma USA, Inc. | 4 | $229 |
| Neos Therapeutics, LP | 16 | $229 |
| Almatica Pharma LLC | 13 | $216 |
| Novo Nordisk | 15 | $202 |
| Merck | 7 | $108 |
| Indivior Inc. | 6 | $100 |
| Noven Therapeutics, LLC | 2 | $41 |
| Avanir Pharmaceuticals, Inc. | 3 | $41 |
| Sunovion Pharmaceuticals Inc. | 5 | $40 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,750 in reported general payments places this provider in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.
Other psychiatry in Moosic
- Matthew BergerMoosic$1.7M
- Satish MallikMoosic$20K
- Rebecca RomaPittsburgh$3.3M
- Robert NelsonWyomissing$2.2M
- Mark MattaNew Castle$847K
- Mayer AyyashPittsburgh$714K
- Daniel WeintraubPhiladelphia$647K
- Sachin MehtaBlue Bell$646K
- Jane JesseKingston$617K
- Michael ThasePhiladelphia$396K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.